Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer epigenetics: Moving forward
Angela Nebbioso, Francesco Paolo Tambaro, Carmela Dell’Aversana, et al.
PLoS Genetics (2018) Vol. 14, Iss. 6, pp. e1007362-e1007362
Open Access | Times Cited: 415

Showing 1-25 of 415 citing articles:

Hallmarks of Cancer: New Dimensions
Douglas Hanahan
Cancer Discovery (2022) Vol. 12, Iss. 1, pp. 31-46
Open Access | Times Cited: 3290
Molecular profiling for precision cancer therapies
Eoghan Ruadh Malone, Marc Oliva, Peter Sabatini, et al.
Genome Medicine (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 703
Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Shannon Lee, Jens Rauch, Walter Kölch
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1102-1102
Open Access | Times Cited: 637
Metabolism of Amino Acids in Cancer
Zhen Wei, Xiaoyi Liu, Chunming Cheng, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 301
DNA hypermethylation in disease: mechanisms and clinical relevance
Melanie Ehrlich
Epigenetics (2019) Vol. 14, Iss. 12, pp. 1141-1163
Open Access | Times Cited: 300
Anticancer drug resistance: An update and perspective
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Drug Resistance Updates (2021) Vol. 59, pp. 100796-100796
Open Access | Times Cited: 251
Recent advances in drug delivery systems for targeting cancer stem cells
Hongxia Duan, Yanhong Liu, Zhonggao Gao, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 1, pp. 55-70
Open Access | Times Cited: 195
Mechanisms for estrogen receptor expression in human cancer
Hui Hua, Hongying Zhang, Qingbin Kong, et al.
Experimental Hematology and Oncology (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 186
Mitochondrial mutations and mitoepigenetics: Focus on regulation of oxidative stress-induced responses in breast cancers
Kuo Chen, Pengwei Lu, Narasimha M. Beeraka, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 556-569
Closed Access | Times Cited: 167
Epigenetics of Aging and Aging-Associated Diseases
Dominik Saul, Robyn Laura Kosinsky
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 401-401
Open Access | Times Cited: 167
Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype
Vincenzo Carafa, Lucia Altucci, Angela Nebbioso
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 155
Anti-inflammatory and immunoregulatory effects of icariin and icaritin
Zhangyang Bi, Wei Zhang, Xiaoyan Yan
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113180-113180
Open Access | Times Cited: 124
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
Mengshu You, Zhuolin Xie, Nan Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 123
Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing
Alexander E. Kabakov, A. O. Yakimova
Cancers (2021) Vol. 13, Iss. 5, pp. 1102-1102
Open Access | Times Cited: 105
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1049-1082
Open Access | Times Cited: 86
Short-chain fatty acids in cancer pathogenesis
Mark A. Feitelson, Alla Arzumanyan, Arvin Medhat, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 677-698
Open Access | Times Cited: 48
An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review
Zahra Sahafnejad, Shahin Ramazi, Abdollah Allahverdi
Genes (2023) Vol. 14, Iss. 4, pp. 873-873
Open Access | Times Cited: 43
Cancer, metastasis, and the epigenome
Saurav Kiri, Tyrone Ryba
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Oncogenes and tumor suppressor genes: functions and roles in cancers
Tikam Chand Dakal, Bhanupriya Dhabhai, Anuja Pant, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 20
Multi-action Pt(IV) anticancer agents; do we understand how they work?
Dan Gibson
Journal of Inorganic Biochemistry (2018) Vol. 191, pp. 77-84
Closed Access | Times Cited: 146
Epigenetic and epitranscriptomic regulation of viral replication
Kevin Tsai, Bryan R. Cullen
Nature Reviews Microbiology (2020) Vol. 18, Iss. 10, pp. 559-570
Open Access | Times Cited: 135
Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings
Lukasz Smigielski, Vinita Jagannath, Wulf Rössler, et al.
Molecular Psychiatry (2020) Vol. 25, Iss. 8, pp. 1718-1748
Closed Access | Times Cited: 132
MicroRNA Networks Modulate Oxidative Stress in Cancer
Yang-Hsiang Lin
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4497-4497
Open Access | Times Cited: 105
Epigenetic mechanisms and the hallmarks of cancer: an intimate affair.
Nadine Darwiche
PubMed (2020) Vol. 10, Iss. 7, pp. 1954-1978
Closed Access | Times Cited: 90
DNA methylation in the pathogenesis of polycystic ovary syndrome
Edgar Ricardo Vázquez-Martínez, Yadira Inés Gómez-Viais, Elizabeth García-Gómez, et al.
Reproduction (2019) Vol. 158, Iss. 1, pp. R27-R40
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top